Related Experiment Video
Updated: Sep 23, 2025

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction
Published on: May 28, 2019
Gradual Versus Abrupt Reperfusion During Primary Percutaneous Coronary Interventions in ST-Segment-Elevation
Murat Sezer1,2, Javier Escaned3, Christopher J Broyd4
1Department of Cardiology Istanbul Faculty of Medicine Istanbul University Istanbul Turkey.
Insights
Pressure-controlled reperfusion with delayed stenting (PCRDS) in ST-segment-elevation myocardial infarction patients preserved microvascular integrity and reduced infarct size compared to immediate stenting. This approach offers a safer alternative for managing myocardial infarction reperfusion injury.
Area of Science:
- Cardiology
- Interventional Cardiology
- Cardiovascular Research
Background:
- Microvascular damage from edema and hemorrhage is a key issue in ST-segment-elevation myocardial infarction (STEMI) reperfusion.
- Primary percutaneous coronary intervention (PCI) can abruptly restore pressure and flow, potentially worsening microvascular injury.
- Investigating methods to mitigate reperfusion injury during primary PCI is crucial for STEMI management.
Purpose of the Study:
- To evaluate if pressure-controlled reperfusion via gradual reopening of the infarct-related artery can limit microvascular injury in STEMI patients undergoing primary PCI.
- To compare the effects of pressure-controlled reperfusion with delayed stenting (PCRDS) versus standard immediate stenting (IS) on coronary microvascular function and infarct size.
Main Methods:
- A randomized trial comparing PCRDS (n=10) with IS (n=10) in STEMI patients with occluded infarct-related arteries.
- PCRDS involved initial reperfusion with a 1.5-mm balloon followed by pressure control for 30 minutes before stenting.
- Coronary hemodynamics, including intracoronary pressure and Doppler flow velocity, were continuously assessed. The primary endpoint was zero flow pressure after a 60-minute monitoring period.
Main Results:
- PCRDS resulted in significantly lower distal intracoronary pressures compared to IS (71.2±9.37 mmHg vs. 90.13±12.09 mmHg, P=0.001).
- Microvascular resistance was significantly lower in the PCRDS group (1.83±0.53 vs. 2.83±0.56 mmHg·s·cm⁻¹, P=0.001), indicating better microcirculatory function.
- The primary endpoint, zero flow pressure, was significantly lower in PCRDS (41.46±17.85 mmHg vs. 76.87±21.34 mmHg, P=0.001), and myocardial infarction size was smaller (peak Troponin T: 5395±2991 ng/mL vs. 8874±1927 ng/mL, P=0.006).
Conclusions:
- Pressure-controlled reperfusion with delayed stenting (PCRDS) effectively preserves coronary microvascular integrity in STEMI patients undergoing primary PCI.
- This technique leads to smaller myocardial infarction sizes compared to standard immediate stenting.
- PCRDS is a safe and effective alternative, demonstrating improved outcomes without increased procedural complications.
Abstract:
Background Intramyocardial edema and hemorrhage are key pathological mechanisms in the development of reperfusion-related microvascular damage in ST-segment-elevation myocardial infarction. These processes may be facilitated by abrupt restoration of intracoronary pressure and flow triggered by primary percutaneous coronary intervention. We investigated whether pressure-controlled reperfusion via gradual reopening of the infarct-related artery may limit microvascular injury in patients undergoing primary percutaneous coronary intervention. Methods and Results A total of 83 patients with ST-segment-elevation myocardial infarction were assessed for eligibility and 53 who did not meet inclusion criteria were excluded. The remaining 30 patients with totally occluded infarct-related artery were randomized to the pressure-controlled reperfusion with delayed stenting (PCRDS) group (n=15) or standard primary percutaneous coronary intervention with immediate stenting (IS) group (n=15) (intention-to-treat population). Data from 5 patients in each arm were unsuitable to be included in the final analysis. Finally, 20 patients undergoing primary percutaneous coronary intervention who were randomly assigned to either IS (n=10) or PCRDS (n=10) were included. In the PCRDS arm, a 1.5-mm balloon was used to achieve initial reperfusion with thrombolysis in myocardial infarction grade 3 flow and, subsequently, to control distal intracoronary pressure over a 30-minute monitoring period (MP) until stenting was performed. In both study groups, continuous assessment of coronary hemodynamics with intracoronary pressure and Doppler flow velocity was performed, with a final measurement of zero flow pressure (primary end point of the study) at the end of a 60-minute MP. There were no complications associated with IS or PCRDS. PCRDS effectively led to lower distal intracoronary pressures than IS over 30 minutes after reperfusion (71.2±9.37 mm Hg versus 90.13±12.09 mm Hg, P=0.001). Significant differences were noted between study arms in the microcirculatory response over MP. Microvascular perfusion progressively deteriorated in the IS group and at the end of MP, and hyperemic microvascular resistance was significantly higher in the IS arm as compared with the PCDRS arm (2.83±0.56 mm Hg.s.cm-1 versus 1.83±0.53 mm Hg.s.cm-1, P=0.001). The primary end point (zero flow pressure) was significantly lower in the PCRDS group than in the IS group (41.46±17.85 mm Hg versus 76.87±21.34 mm Hg, P=0.001). In the whole study group (n=20), reperfusion pressures measured at predefined stages in the early reperfusion period showed robust associations with zero flow pressure values measured at the end of the 1-hour MP (immediately after reperfusion: r=0.782, P<0.001; at the 10th minute: r=0.796, P<0.001; and at the 20th minute: r=0.702, P=0.001) and peak creatine kinase MB level (immediately after reperfusion: r=0.653, P=0.002; at the 10th minute: r=0.597, P=0.007; and at the 20th minute: r=0.538, P=0.017). Enzymatic myocardial infarction size was lower in the PCRDS group than in the IS group with peak troponin T (5395±2991 ng/mL versus 8874±1927 ng/mL, P=0.006) and creatine kinase MB (163.6±93.4 IU/L versus 542.2±227.4 IU/L, P<0.001). Conclusions In patients with ST-segment-elevation myocardial infarction, pressure-controlled reperfusion of the culprit vessel by means of gradual reopening of the occluded infarct-related artery (PCRDS) led to better-preserved coronary microvascular integrity and smaller myocardial infarction size, without an increase in procedural complications, compared with IS. Registration URL: https://www.clinicaltrials.gov; Unique identifier: NCT02732080.
More Related Videos
18:11A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis
Published on: December 28, 2012
05:41Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control
Published on: December 16, 2022
Related Concept Videos
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome IV: Interprofessional Care
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Acute Coronary Syndrome III: Diagnostic Studies